Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03529071 · ClinicalTrials.gov registry record · NA
Empowering Veterans to Communicate With Healthcare Providers
A NA study, sponsored by Northwestern University.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT03529071: Clinical Trial NA study, sponsored by Northwestern University.
NCT03529071 is a NA study that was terminated before completion, run by Northwestern University. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03529071, a NA study, was terminated before completion, sponsored by Northwestern University.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The goal of this VA Innovation Seed project is to test the best approach for the delivery, feasibility, and usability of a patient-centered CKD-QPS to facilitate better Veteran understanding and engagement in their CKD-care in nephrology clinics at two geographically distinct VA hospitals (Chicago and Dallas) through on-going user feedback in real time.
Primary Outcome
This measure, the full name of which is provided above, assesses patients' perceived self-efficacy or confidence in interacting with physicians. It includes 5 items, each of which is anchored by 1 (not at all confident) and 5 (very confident). Scores range from 5 to 25, which higher scores indicating greater confidence.
Interventions
- BEHAVIORAL CKD-Question Prompt Sheet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2018-09-17 |
| Est. Completion | 2018-09-30 |
| Phase | NA |
Why NCT03529071 stopped before completion
NCT03529071 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which CKD-Question Prompt Sheet is the first listed.
NCT03529071 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03529071 about?
NCT03529071 is a clinical study titled "Empowering Veterans to Communicate With Healthcare Providers". The goal of this VA Innovation Seed project is to test the best approach for the delivery, feasibility, and usability of a patient-centered CKD-QPS to facilitate better Veteran understanding and engagement in their CKD-care in nephrology clinics at two geographically distinct VA hospitals (Chicago a...
What is the current status of trial NCT03529071?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2018-09-17. Estimated completion is 2018-09-30.
What interventions are being tested in trial NCT03529071?
The interventions under investigation include: CKD-Question Prompt Sheet (BEHAVIORAL).
Who is sponsoring clinical trial NCT03529071?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03529071's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI